Overview The COVID-19 pandemic has disrupted much of the research and development done in the field of tuberculosis (TB) prevention, diagnostics, and treatment measures, as well as shifted the focus away from TB care. Lockdowns and the high burden placed on national healthcare systems has prevented patients from accessing TB diagnostic and treatment services, and it is expected that this will contribute to a significant rise in TB cases worldwide, thus reducing the chances of achieving the SDG, EndTB and UN HLM targets.

 

Read more ERS…